Singapore’s population is uniquely vulnerable to eye diseases and disorders at every life stage. One in two children develops myopia by the age of 12. At 18, 83% will turn myopic.
A life-long condition, people who contract myopia at a young age may easily develop high myopia, where they have myopic degrees of over 800 in both
eyes. High myopia can lead to serious complications, low vision and even blindness as early as mid-adulthood.
In working-age adults, diabetic retinopathy is the leading cause of vision loss. According to a study led by researchers at the
Singapore Eye Research Institute (SERI) in 2015, diabetic retinopathy has to date claimed the sight of more than 600 Singaporeans, the loss of an eye in 8,000, and visual impairment in a further 17,500.
The problem worsens as the risk of blindness increases fifteen-fold for Singaporeans aged 50 to 80 and above. As age steals away the senses, vision loss is perhaps the most devastating, as it increases the risk of falls, depression and even premature death.
We urgently need to invest in educational, research and treatment initiatives for all Singaporeans, to address these public health concerns.
VisionSave, a joint effort between SNEC and SERI, needs your help to bring eye health into the spotlight.
Your donations will enable us to engage the broader community, private and commercial partners, and empower our patients who have benefited and are keen to give back.
We need your support to develop complex, cutting-edge and novel therapies and surgical techniques for sight-threatening eye diseases.
The funds donated will go towards the five causes that serve as integral drivers in our efforts to initiate life-changing outcomes for patients:
Click on each area to find out more.
Provide financial assistance for needy patients with sight-threatening diseases
Educate people in the areas of saving sight
Develop long-term understanding of eye diseases and solutions
Support research and innovation in the field of ophthalmology
Build strong infrastructure and invest in capacity building
Subscribe to our mailing list to get the updates to your email inbox...